CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

105 hedge funds and large institutions have $305M invested in Carisma Therapeutics in 2021 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

36% more call options, than puts

Call options by funds: $6.74M | Put options by funds: $4.96M

0.73% more ownership

Funds ownership: 1.18%1.91% (+0.73%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
105
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.74M
Puts
$4.96M
Net Calls
Net Calls Change

Top Buyers

1 +$62.6M
2 +$35.7M
3 +$7.15M
4
Northern Trust
Northern Trust
Illinois
+$6.41M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.04M

Top Sellers

1 -$11.5M
2 -$3.41M
3 -$1.72M
4
Wells Fargo
Wells Fargo
California
-$1.33M
5
VF
Virtu Financial
New York
-$1.08M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$70K
77
$62K
78
$60K
79
$60K
80
$59K
81
$56K
82
$55K
83
$51K
84
$49K
85
$49K
86
$49K
87
$46K
88
$46K
89
$46K
90
$40K
91
$33K
92
$30.4K
93
$29K
94
$28K
95
$19K
96
$18K
97
$9K
98
$8K
99
$6K
100
$6K